health-news

'Alzheimer's drug to be developed within five years'

Washington, Dec. 5 : Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.


Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.

In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.

Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.

Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.

--ANI (Posted on 05-12-2013)

health-news headlines

How food texture affects our calorie intake

Cheap 'magic' polypill helps fight heart diseases

Extroverts make for happier humans across cultures

Low-calorie restaurant menus may be making us unhealthier

Why rice is good for your health

Pregnant women with high BP risk preterm delivery and low birth weight

Casual marijuana use could lead to brain abnormalities in young adults

Antibiotics improve growth in kids in developing countries

Anti-depressants during pregnancy linked to autism and developmental delays in boys

Girls' mental health suffers when romances play out differently than they imagined

Now, faster, cheaper blood test to accurately diagnose asthma

Genetic therapy may repair spinal chord: Study

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top